Effect of Puberty on the Pharmacodynamic and Pharmacokinetic Properties of Insulin Pump Therapy in Youth With Type 1 Diabetes-Reference-Cited by-同舟云学术

Effect of Puberty on the Pharmacodynamic and Pharmacokinetic Properties of Insulin Pump Therapy in Youth With Type 1 Diabetes

Published:2008-01-01 Issue:1 Volume:31 Page:44-46
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Swan Karena L.¹,Weinzimer Stuart A.¹,Dziura James D.²,Steil Garry M.³,Voskanyan Gayane R.³,Steffen Amy T.¹,Martin Melody L.¹,Tamborlane William V.¹²

Affiliation:

1. Section of Pediatric Endocrinology, Yale University, New Haven, Connecticut

2. Center for Clinical Investigation, Yale University, New Haven, Connecticut

3. Medtronic MiniMed, Northridge, California

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/31/1/44/598438/zdc00108000044.pdf

Reference10 articles.

1. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396–402, 1994

2. Mudaliar S, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR: Insulin aspart (B28 Asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 22:1501–1506, 1999

3. Becker RHA, Frick A, Wessels D, Scholtz H: Evaluation of the pharmacodynamic and pharmacokinetic profiles of insulin glulisine-a novel, rapid-acting, human insulin analogue (Abstract). Diabetologia 46:775, 2003

4. Becker RHA, Frick AD, Kapitza C, Heise T, Rave K: Pharmacodynamics (PD) and pharmacokinetics (PK) of insulin glulisine (GLU) versus insulin lispro (IL) and regular human insulin (RHI) in patients with type 2 diabetes (Abstract). Diabetes 53 (Suppl. 2):A119, 2004

5. Danne T, Becker RHA, Heise T, Bittner C, Frick AD, Rave K: Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 28:2100–2105, 2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence and Machine Learning for Improving Glycemic Control in Diabetes: Best Practices, Pitfalls, and Opportunities;IEEE Reviews in Biomedical Engineering;2024

2. MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience;Diabetes Technology & Therapeutics;2023-09-01

3. Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes Registry;Pediatric Diabetes;2023-08-09

4. Questionnaire-based service evaluation of the efficacy and usefulness of SEREN: a structured education programme for children and young people diagnosed with type 1 diabetes mellitus;BMJ Open Quality;2021-09

5. Diabetes Mellitus;Sperling Pediatric Endocrinology;2021